5L87
Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat trypanosomiases.
GO(遺伝子オントロジー)由来の情報
鎖名 | GO(遺伝子オントロジー)id | 名前空間 | 内容 |
A | 0005778 | cellular_component | peroxisomal membrane |
A | 0016560 | biological_process | protein import into peroxisome matrix, docking |
PDBデータベースに由来する情報
site_id | AC1 |
残基数 | 19 |
詳細 | binding site for residue 6RD A 101 |
鎖名 | 残基 |
A | ASN13 |
A | LYS38 |
A | ARG63 |
A | HOH235 |
A | HOH257 |
A | HOH257 |
A | HOH266 |
A | HOH325 |
A | HOH328 |
A | HOH329 |
A | HOH331 |
A | GLU16 |
A | ASP20 |
A | ARG22 |
A | VAL23 |
A | HIS33 |
A | PHE34 |
A | LEU35 |
A | SER37 |
site_id | AC2 |
残基数 | 8 |
詳細 | binding site for residue EDO A 102 |
鎖名 | 残基 |
A | LYS56 |
A | LYS56 |
A | THR57 |
A | THR57 |
A | HOH214 |
A | HOH214 |
A | HOH255 |
A | HOH255 |